With just a few hours left for the year to end, it can be said that 2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to several i...
The XRP price has soared over the weekend to overtake Ethereum as the second largest cryptocurrency in the world, thanks to three of the credit card majors from Japan and other...
Following the ideas of Keynes and Friedman, most mainstream economists associate economic growth with increases in the demand for goods and services. Both Keynes and Friedman felt ...
USD/CAD broke below 1.2623 support, indicating that the upside movement from 1.2061 had completed at 1.2916 already. A deeper decline to test 1.2433 support could be seen next week...
The pharma/biotech industry was plagued by drug pricing issues last year. However, it bounced back and made a considerable headway this year, courtesy of a slew of FDA approvals. P...
The last Housing Market Review covered data reported in November, 2017 for October, 2017. At the time, the iShares U.S. Home Construction ETF (ITB) traded at a 10+ year high withÂ...
It goes without saying that one of the tragedies of 2017 was the relegation of reality to the backburner of public discourse. I’m not much on the notion that there is an objectiv...
The goal of most investors is to either: Maximize returns given a fixed level of risk Minimize risk given a particularly level of desired returns Perhaps the best metric for analyz...
2017 was another year of learning and trying to spread that education to the readers here. I am so grateful for all the people who find the content here useful and provide feedback...
Below is a list of the most read of our blog articles in each month during 2017. One interesting commonality for some of the top posts is the fact the ones focusing on investor sen...